Well that concerns me. Everytime Cramer gets interested in a stock, it tanks it seems.
Completely agree. The pumping is so small-minded and sounds very penny-stock investorish. Unless the company fails to execute, the drug has some unforeseen problems, or something out of left-field happens, the stock will invariably reward patient investors here.